NDC 70261-519

Tim-Dor PF

Timolol - Dorzolamide Pf

Tim-Dor PF is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimisrx Nj. The primary component is Timolol Maleate; Dorzolamide Hydrochloride.

• Product ID: 70261-519_6bb5919c-dd15-10e8-e053-2991aa0a6695
• NDC: 70261-519
• Product Type: Human Prescription Drug
• Proprietary Name: Tim-Dor PF
• Generic Name: Timolol - Dorzolamide Pf
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2018-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: ImprimisRx NJ
• Substance Name: TIMOLOL MALEATE; DORZOLAMIDE HYDROCHLORIDE
• Active Ingredient Strength: 5 mg/mL; mg/mL
• Pharm Classes: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 70261-519-10

10 mL in 1 BOTTLE, DROPPER (70261-519-10)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70261-519-10 [70261051910]

Tim-Dor PF SOLUTION/ DROPS

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
TIMOLOL MALEATE	5 mg/mL

OpenFDA Data

• SPL SET ID: 6bb5919c-dd14-10e8-e053-2991aa0a6695
• Manufacturer:
  • ImprimisRx NJ
• UNII:
  • QZO5366EW7
  • P8Y54F701R
• RxNorm Concept Unique ID - RxCUI:
  • 1922783

Pharmacological Class

• Adrenergic beta-Antagonists [MoA]
• beta-Adrenergic Blocker [EPC]
• Carbonic Anhydrase Inhibitor [EPC]
• Carbonic Anhydrase Inhibitors [MoA]